Research Progress on the Anticancer Activity of Natural Indole Alkaloids
Archiv der Pharmazie · 2026
DOI: 10.1002/ardp.70246 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archiv der Pharmazie, 2026. Verfasst von Wanqing Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, People's Republic of China. Hauptthemen laut MEDLINE: Neoplasms, Indole Alkaloids, Antineoplastic Agents, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 66 Literaturangaben.
Abstract (Originalsprache)
Cancer poses a devastating global threat, inflicting immense physical suffering, high mortality rates, severe psychological distress, and substantial economic burdens on individuals, families, and healthcare systems worldwide while gravely compromising quality of life and leaving long‐lasting impacts on affected communities. As a fundamental and versatile modality for cancer treatment, chemotherapy exerts a pivotal effect in shrinking tumors, eliminating residual cancer cells, alleviating symptoms, and improving survival rates across various cancer types, whether utilized as monotherapy or in combination with surgery, radiotherapy, or targeted therapies. However, chemotherapy is hampered by several key limitations. The primary drawbacks are tumor cell multidrug resistance, which culminates in impaired drug responsiveness and ultimately treatment failure, and non‐specific cytotoxicity, which elicits off‐target adverse effects in normal tissues. Accordingly, the development of novel anticancer agents remains an indispensable research priority in contemporary oncology. Natural indole alkaloids, a diverse class of natural secondary metabolites, exhibit notable advantages for cancer therapy, including high target selectivity, multiple anticancer mechanisms, favorable biocompatibility, and ample sources for lead compound discovery. Their structural diversity enables specific binding to cancer‐associated molecular targets, while their structural modifiability further optimizes pharmacokinetic profiles, rendering them promising candidates for advancing the development of novel anticancer therapeutics. This review summarizes the recent research progress on natural indole alkaloids with anticancer therapeutic potential, developed over the period 2021 to the present, aiming to provide novel insights for the discovery of innovative anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, People's Republic of China.
- Key Laboratory of Traditional Chinese Medicine in Medical Institutions of Fujian Province, Fuzhou, People's Republic of China.
ORCID-Profile: Wanqing Zheng
Zitieren
APA
Zheng, W., Zhang, K., Fan, X., Zheng, W., He, D., & Zeng, M. (2026). Research Progress on the Anticancer Activity of Natural Indole Alkaloids. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70246
Vancouver
Zheng W, Zhang K, Fan X, Zheng W, He D, Zeng M. Research Progress on the Anticancer Activity of Natural Indole Alkaloids. Archiv der Pharmazie. 2026. doi:10.1002/ardp.70246
BibTeX
@article{Zheng2026,
author = {Zheng, Wanqing and Zhang, Kuan and Fan, Xianghui and Zheng, WenWei and He, Da and Zeng, Maogui},
title = {Research Progress on the Anticancer Activity of Natural Indole Alkaloids},
journal = {Archiv der Pharmazie},
year = {2026},
doi = {10.1002/ardp.70246}
}
EUVIMED